Phase I, Open-Label, Randomized, 3-Way Crossover Study to Assess Relative Bioavailability of Single Oral Dose of Naproxen as PN400 Compared to Naproxen as Proxen S and Naprosyn E in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 08 Dec 2010
At a glance
- Drugs Esomeprazole/naproxen; Naproxen
- Indications Arthritis; Musculoskeletal pain; NSAID-induced gastrointestinal damage
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 18 Mar 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 18 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Oct 2008 New trial record.